Reperfusion therapy is a medical treatment that is used to restore blood flow, either around blocked arteries, basically after a heart attack or myocardial infarction (MI). This therapy includes drugs and surgery. The drugs which can be used include thrombolytic and fibrinolysis used in a process and is called thrombolysis. The surgeries performed may be minimally-invasive endovascular procedures such as coronary angioplasty, percutaneous coronary intervention (PCI). The angioplasty utilizes the insertion of a balloon to open up the artery, with the possible additional use of one or more stents. The various other surgeries performed are the higher invasive bypass surgeries that graft arteries around blockages.
COVID-19 scenario analysis:
The rise in the number of individuals experiencing coronavirus disease-2 has led a global concern for protection, due to which lockout situation was declared. Due to this lockout situation, there has been a halt in the manufacturing of various pharmaceutical products, which is causing economic recession. The Covid-19 pandemic has negatively impacted on the healthcare system, and causing about 50% to 70% drop in revenue since March. The smaller organizations such as, small hospitals, clinics and nursing homes, are announced to be kept shut during the period, and hence affected the economic growth of the majority of the sectors. This is has reduced the number of the surgical procedures. Furthermore, rise in number of visa cancellations has reduced revenue due to medical tourism, hence is affecting the economy negatively in the current scenario.
Top impacting factors: Market Scenario Analysis, Trends, Drivers and Impact Analysis
The key factors affecting the industrial growth include the rise in number of cardiovascular diseases and increase in individuals adapting unhealthy lifestyle, which would help the market grow significantly during the forecast period. Furthermore, rise in geriatric population would help the market boost in the coming year. However, the lack of skilled professionals, may hinder the industrial growth in the commenced period.
New product advancements to flourish the market
In July 2016, Penumbra announced the launch of the Ace68 Reperfusion thrombectomy catheter in the U.S. This product is designed for extracting thrombus in acute ischemic stroke patients mainly. The Ace68 catheter was engineered on an entirely novel platform from hub to tip, which features coil winding geometry along 16 transitions to create a more optimal tracking profile.
In July 2019, Penumbra announced commercial availability of the Penumbra System’s most advanced technology in the U.S. The Penumbra Jet 7 Reperfusion Catheter with Xtra Flex technology, at the Society of NeuroInterventional Surgery (SNIS) 16th Annual Meeting. Penumbra Jet 7 with Xtra Flex technology is used with the Penumbra Engine in the fully integrated Penumbra System, an aspiration-based mechanical thrombectomy system that allows physicians to extract thrombus in acute ischemic stroke patients.
Surge in incidences of the diseases which need the therapy to boost the market
According to the estimates given by the World Health Organization, the major cause of death is cardiovascular diseases. The number deaths are about 17.9 million, caused due to cardiovascular diseases. Four out of Five of the Cardiovascular Diseases, are the deaths due to heart attacks and strokes, and one third of these deaths occur earlier in people, who are under 70 years of age.
According to the estimates given by the Center of Disease Control and Prevention, the heart diseases are among the major causes of deaths in the U.S., one person dies every 37 seconds. This alarming rate has drastically gained the attention of the majority of the population.
Key benefits of the report:
- This study presents the analytical depiction of the global reperfusion therapy industry along with the current trends and future estimations to determine the imminent investment pockets.
- The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global reperfusion therapy market share.
- The current market is quantitatively analyzed to highlight the global reperfusion therapy market growth scenario.
- Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
- The report provides a detailed global reperfusion therapy market analysis based on competitive intensity and how the competition will take shape in coming years.
Questions answered in the reperfusion therapy market research report:
- What are the leading market players active in the reperfusion therapy market?
- What current trends will influence the market in the next few years?
- What are the driving factors, restraints, and opportunities in the market?
- What are the projections for the future that would help in tasking further strategic steps?
Reperfusion Therapy Market Report Highlights
| Aspects | Details |
 By Application Type |
|
 By Drug |
|
 By End User |
|
 By Region |
|
 Key Market Players | MIFCOR, Inc., Mallinckrodt Pharmaceuticals, Amyndas Pharmaceuticals, CFM Pharma Holding B.V., Balmes Transplantation SAS, Angion Biomedica Corp., SBI Holdings Inc., Revive Therapeutics Ltd., Corline Biomedical AB, Faraday Pharmaceuticals, Pharming Group NV, Radikal Therapeutics Inc. |
Loading Table Of Content...
